#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Neuroendocrine carcinoma Primitive neuroectodermal tumour Pulmonary arterial hypertension Thermal burn Obesity Astrocytoma malignant Thrombotic microangiopathy Osteopetrosis Mucous membrane pemphigoid Vaginal cancer Skin cancer Kaposi's sarcoma Usher's syndrome Osteomyelitis More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Primary biliary cholangitis – Trials in Disease Ewing’s sarcoma recurrent – Treatment Systemic mastocytosis – Treatment Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease Lymphangioma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Mucopolysaccharidosis II – Diagnostics Mucopolysaccharidosis III – Basic Information More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    S227928 Spesolimab Imipenem Dextromethorphan Hydrobromide Lisdexamfetamine Dimesylate Pembrolizumab Trimetazidine Dihydrochloride Alxn1850 AVTX-009 Hypromellose Rimegepant Clebopride Hydrogen Maleate Propafenone Hydrochloride Trametinib Dimethyl Sulfoxide Treosulfan Vosoritide Dexamethasone Ph. Eur. Patritumab Deruxtecan Tanimilast Keto-Leucine Calcium More therapies…

    Learn about Your Condition

    Anogenital warts Corneal dystrophy Primary hyperoxaluria Ejection fraction normal Andersen-Tawil syndrome Colorectal cancer metastatic Hydrocele ROHHAD syndrome Uveal melanoma Postprandial hypoglycaemia Transient ischaemic attack Urethral stenosis Radicular pain Respiratory distress Onychomycosis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Dapagliflozin on Heart Function in Patients with Chronic Kidney Disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    • Chronic kidney disease
    Investigated drugs:
    • Dapagliflozin Propanediol
    Denmark
  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • IgA nephropathy
    Investigated drugs:
    • Losartan Potassium
    • Methylprednisolone Sodium Succinate
    • Ramipril
    Italy
  • Study on Posaconazole and Fluconazole for Preventing Fungal Infections in Patients with Acute Myeloid Leukemia

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Fungal infection
    Investigated drugs:
    • Fluconazole
    • Posaconazole
    Belgium France
  • Study of Donor Specific Immunomodulatory Cells (DSIMC) for Patients with End-Stage Liver Disease Undergoing Liver Transplantation

    Not yet recruiting

    3 1 1
    Investigated diseases:
    • Liver transplant
    Investigated drugs:
    • Dsimc
    Sweden
  • Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Transitional cell carcinoma
    Investigated drugs:
    • Gemcitabine
    The Netherlands Norway Spain
  • Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Tuberculosis
    Investigated drugs:
    • Pyrazinamide
    • Rifampicin
    Sweden
Previous Page
1 … 890 891 892 893 894 … 1,614
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!